Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$2.2 - $4.45 $67,249 - $136,027
-30,568 Closed
0 $0
Q3 2020

May 24, 2024

BUY
$2.62 - $4.78 $80,088 - $146,115
30,568 New
30,568 $123 Million
Q3 2020

Jun 26, 2023

BUY
$2.62 - $4.78 $80,088 - $146,115
30,568 New
30,568 $123,000
Q3 2020

Mar 22, 2023

BUY
$2.62 - $4.78 $80,088 - $146,115
30,568 New
30,568 $123,000
Q3 2020

Nov 13, 2020

BUY
$2.62 - $4.78 $80,088 - $146,115
30,568 New
30,568 $123,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $173M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.